Phinma Corporation (PHN)

Overview

Pharmanutra S.p.A. is a distinguished entity in the pharmaceutical and nutraceutical industry, focusing on the research, design, development, and marketing of nutritional supplements and medical devices. With a foundation laid in 2003 and headquartered in Pisa, Italy, the company has carved its niche both domestically and internationally. It operates across several regions, including Europe, the Middle East, Africa, and the Far East, delivering a wide spectrum of products. Besides its expansive range of nutritional supplements and medical devices, Pharmanutra S.p.A. also engages in the production and marketing of pharmaceuticals, over-the-counter (OTC) products, and nutraceuticals specifically crafted for the pediatric sector. Furthermore, it extends its expertise to producing and distributing raw materials and active ingredients vital for the food, pharmaceutical, and food supplement industries. Distribution and sales are effectively conducted through a network of sales representatives, wholesalers, pharmacies, and para-pharmacies, ensuring wide accessibility to its offerings.

Products and Services

The product range of Pharmanutra S.p.A. is diverse, catering to various health needs and sectors:

• SiderAL: A series of iron supplements designed to offer an innovative solution for iron deficiency with minimal gastrointestinal side effects. Includes variants like SiderAL Forte, SiderAL Folic, and Cardio SiderAL for specific needs.
• SiderAL Med: Tailored for specialized medical uses, enhancing the options available for managing iron-related conditions.
• Cetilar Crema, Cetilar Patch, Cetilar Tape, and Cetilar Oro: A range of products aimed at pain relief and joint health, integrating the Cetilar line to cater to different consumer preferences and application methods.
• ApportAL: Focused on providing essential vitamins and minerals to support overall health and wellbeing.
• UltraMag: A magnesium supplement designed to combat magnesium deficiency and support muscle and nerve function.
• Gestalys DHA: Tailored for pregnant and breastfeeding mothers, offering DHA supplementation important for the development of the baby’s brain and eyes.
• Novomega: A high-quality omega-3 supplement, aiming at improving cardiovascular health and reducing inflammation.
• Bonecal: Primarily focused on bone health, providing essential nutrients like calcium and vitamin D to support bone density and structure.
• DiKappa 2: Addresses specific nutritional needs with a comprehensive formula, supporting overall health through targeted supplementation.

With such a diverse product lineup, Pharmanutra S.p.A. stands out as a comprehensive provider of health solutions in the pharmaceutical and nutraceutical domain, offering innovative and effective options to meet a range of dietary and medical needs.